We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.

Show simple item record

Current and emerging treatments for vitiligo

dc.contributor.authorRodrigues, Michelle
dc.contributor.authorEzzedine, Khaled
dc.contributor.authorHamzavi, Iltefat
dc.contributor.authorPandya, Amit G.
dc.contributor.authorHarris, John E.
dc.date2022-08-11T08:09:21.000
dc.date.accessioned2022-08-23T16:27:12Z
dc.date.available2022-08-23T16:27:12Z
dc.date.issued2017-07-01
dc.date.submitted2017-07-20
dc.identifier.citationJ Am Acad Dermatol. 2017 Jul;77(1):17-29. doi: 10.1016/j.jaad.2016.11.010. <a href="https://doi.org/10.1016/j.jaad.2016.11.010">Link to article on publisher's site</a>
dc.identifier.issn0190-9622 (Linking)
dc.identifier.doi10.1016/j.jaad.2016.11.010
dc.identifier.pmid28619557
dc.identifier.urihttp://hdl.handle.net/20.500.14038/36730
dc.description.abstractClinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=28619557&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1016/j.jaad.2016.11.010
dc.subjectafamelanotide
dc.subjectbiologics
dc.subjectcorticosteroids
dc.subjectexcimer lamp
dc.subjectexcimer laser
dc.subjectgrafting
dc.subjectleukoderma
dc.subjectmethotrexate
dc.subjectnarrowband ultraviolet light
dc.subjectphototherapy
dc.subjectpigmentation
dc.subjecttacrolimus
dc.subjecttreatment
dc.subjectvitiligo
dc.subjectDermatology
dc.subjectSkin and Connective Tissue Diseases
dc.titleCurrent and emerging treatments for vitiligo
dc.typeJournal Article
dc.source.journaltitleJournal of the American Academy of Dermatology
dc.source.volume77
dc.source.issue1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/metnet_pubs/97
dc.identifier.contextkey10458179
html.description.abstract<p>Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. It is important to recognize common and uncommon presentations and those with active disease, as well as their implications for clinical management; these were discussed in the first article in this continuing medical education series. Existing treatments include topical and systemic immunosuppressants, phototherapy, and surgical techniques, which together may serve to halt disease progression, stabilize depigmented lesions, and encourage repigmentation. We discuss how to optimize the currently available treatments and highlight emerging treatments that may improve treatment efficacy in the future.</p>
dc.identifier.submissionpathmetnet_pubs/97
dc.contributor.departmentDepartment of Dermatology
dc.source.pages17-29


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record